Pharmanovia, a global pharmaceutical company that commercialises novel medicines and revitalises, extends and expands the lifecycle of established medicines, has announced the expansion of its neurology portfolio with the acquisition of 11 central nervous system (CNS) brands from global healthcare company, Sanofi. The brands span four therapy areas of ongoing unmet need associated with CNS…
Sanofi announced that Gaurav Bahadur has resigned from the role of Senior Director – Human Resources, India & South Asia, with effect from August 1, 2023. According to the company’s exchange filing, “Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015 (‘Listing Regulations’), we wish to inform you that Mr. Gaurav…
French drugmaker Sanofi, recently said that it will cut up to 1,680 jobs in Europe in an attempt to cut costs and lift profits. According to a Reuters report, the company currently employs more than 100,000 people worldwide. The downsizing is a part of a broader strategy put in place by company Chief Executive Officer…
Zentiva, a Czech Republic-based company that develops and manufactures generic medicines providing the NHS with low cost alternatives to branded medicines, announced the completion of its acquisition of a manufacturing site in Ankleshwar, India, from Sanofi. The acquisition will increase the number of wholly-owned Zentiva production sites worldwide. The company said that the move will…